MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$38,060K
Cash and cash
equivalents
$19,941K
Prepaid expenses and
other current assets
$1,936K
Total current assets
$59,937K
Long-term investments
$2,013K
Total assets
$61,950K
Total liabilities and
stockholders' equity
$61,950K
Total stockholders'
equity
$53,060K
Total liabilities
$8,890K
Accumulated deficit
-$240,950K
Additional paid-in capital
$293,953K
Total current
liabilities
$8,720K
Other non-current
liabilities
$170K
Accumulated other
comprehensive gain
$57K
Accounts payable
$3,021K
Accrued compensation
$2,418K
Accrued liabilities
$2,052K
Other current
liabilities
$1,229K
Back
Back
Balance Sheet
source: myfinsight.com
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)